Fine Organic Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: May 31, 2025, 9:44 pm

Competitors of Fine Organic Industries Ltd

All Competitor Stocks of Fine Organic Industries Ltd

Quarterly Result

Last Updated: May 31, 2025, 10:00 am

Below is a detailed analysis of the quarterly data for Fine Organic Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 607.00 Cr.. The value appears strong and on an upward trend. It has increased from 517.00 Cr. (Dec 2024) to 607.00 Cr., marking an increase of 90.00 Cr..
• For Expenses, as of Mar 2025, the value is 487.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 414.00 Cr. (Dec 2024) to 487.00 Cr., marking an increase of 73.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 120.00 Cr.. The value appears strong and on an upward trend. It has increased from 103.00 Cr. (Dec 2024) to 120.00 Cr., marking an increase of 17.00 Cr..
• For OPM %, as of Mar 2025, the value is 20.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 20.00%.
• For Other Income, as of Mar 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from 25.00 Cr. (Dec 2024) to 26.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Mar 2025, the value is 1.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Dec 2024) to 1.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Mar 2025, the value is 15.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.00 Cr. (Dec 2024) to 15.00 Cr., marking an increase of 2.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 130.00 Cr.. The value appears strong and on an upward trend. It has increased from 115.00 Cr. (Dec 2024) to 130.00 Cr., marking an increase of 15.00 Cr..
• For Tax %, as of Mar 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 28.00% (Dec 2024) to 25.00%, marking a decrease of 3.00%.
• For Net Profit, as of Mar 2025, the value is 97.00 Cr.. The value appears strong and on an upward trend. It has increased from 83.00 Cr. (Dec 2024) to 97.00 Cr., marking an increase of 14.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 31.68. The value appears strong and on an upward trend. It has increased from 26.97 (Dec 2024) to 31.68, marking an increase of 4.71.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 7:27 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: May 13, 2025, 3:59 pm

Below is a detailed analysis of the balance sheet data for Fine Organic Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 15.00 Cr..
• For Reserves, as of Mar 2025, the value is 2,280.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,906.00 Cr. (Mar 2024) to 2,280.00 Cr., marking an increase of 374.00 Cr..
• For Borrowings, as of Mar 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 4.00 Cr. (Mar 2024) to 3.00 Cr., marking a decrease of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 213.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 182.00 Cr. (Mar 2024) to 213.00 Cr., marking an increase of 31.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,511.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,108.00 Cr. (Mar 2024) to 2,511.00 Cr., marking an increase of 403.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 363.00 Cr.. The value appears strong and on an upward trend. It has increased from 233.00 Cr. (Mar 2024) to 363.00 Cr., marking an increase of 130.00 Cr..
• For CWIP, as of Mar 2025, the value is 27.00 Cr.. The value appears to be declining and may need further review. It has decreased from 30.00 Cr. (Mar 2024) to 27.00 Cr., marking a decrease of 3.00 Cr..
• For Investments, as of Mar 2025, the value is 35.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Mar 2024) to 35.00 Cr., marking a decrease of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,085.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,809.00 Cr. (Mar 2024) to 2,085.00 Cr., marking an increase of 276.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,511.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,108.00 Cr. (Mar 2024) to 2,511.00 Cr., marking an increase of 403.00 Cr..

Notably, the Reserves (2,280.00 Cr.) exceed the Borrowings (3.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Fine Organic Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 134.34. This value is within the healthy range. It has decreased from 201.60 (Mar 23) to 134.34, marking a decrease of 67.26.
• For Diluted EPS (Rs.), as of Mar 24, the value is 134.34. This value is within the healthy range. It has decreased from 201.60 (Mar 23) to 134.34, marking a decrease of 67.26.
• For Cash EPS (Rs.), as of Mar 24, the value is 153.52. This value is within the healthy range. It has decreased from 217.80 (Mar 23) to 153.52, marking a decrease of 64.28.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 626.57. It has increased from 502.69 (Mar 23) to 626.57, marking an increase of 123.88.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 626.57. It has increased from 502.69 (Mar 23) to 626.57, marking an increase of 123.88.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 692.42. It has decreased from 986.00 (Mar 23) to 692.42, marking a decrease of 293.58.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 197.62. This value is within the healthy range. It has decreased from 291.99 (Mar 23) to 197.62, marking a decrease of 94.37.
• For PBIT / Share (Rs.), as of Mar 24, the value is 179.31. This value is within the healthy range. It has decreased from 276.37 (Mar 23) to 179.31, marking a decrease of 97.06.
• For PBT / Share (Rs.), as of Mar 24, the value is 178.33. This value is within the healthy range. It has decreased from 274.88 (Mar 23) to 178.33, marking a decrease of 96.55.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 135.20. This value is within the healthy range. It has decreased from 202.18 (Mar 23) to 135.20, marking a decrease of 66.98.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 134.34. This value is within the healthy range. It has decreased from 201.60 (Mar 23) to 134.34, marking a decrease of 67.26.
• For PBDIT Margin (%), as of Mar 24, the value is 28.54. This value is within the healthy range. It has decreased from 29.61 (Mar 23) to 28.54, marking a decrease of 1.07.
• For PBIT Margin (%), as of Mar 24, the value is 25.89. This value exceeds the healthy maximum of 20. It has decreased from 28.02 (Mar 23) to 25.89, marking a decrease of 2.13.
• For PBT Margin (%), as of Mar 24, the value is 25.75. This value is within the healthy range. It has decreased from 27.87 (Mar 23) to 25.75, marking a decrease of 2.12.
• For Net Profit Margin (%), as of Mar 24, the value is 19.52. This value exceeds the healthy maximum of 10. It has decreased from 20.50 (Mar 23) to 19.52, marking a decrease of 0.98.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 19.40. This value is within the healthy range. It has decreased from 20.44 (Mar 23) to 19.40, marking a decrease of 1.04.
• For Return on Networth / Equity (%), as of Mar 24, the value is 21.44. This value is within the healthy range. It has decreased from 40.10 (Mar 23) to 21.44, marking a decrease of 18.66.
• For Return on Capital Employeed (%), as of Mar 24, the value is 28.58. This value is within the healthy range. It has decreased from 54.94 (Mar 23) to 28.58, marking a decrease of 26.36.
• For Return On Assets (%), as of Mar 24, the value is 19.54. This value is within the healthy range. It has decreased from 34.21 (Mar 23) to 19.54, marking a decrease of 14.67.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.00. This value is within the healthy range. It has decreased from 0.01 (Mar 23) to 0.00, marking a decrease of 0.01.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.08. It has decreased from 2.01 (Mar 23) to 1.08, marking a decrease of 0.93.
• For Current Ratio (X), as of Mar 24, the value is 9.13. This value exceeds the healthy maximum of 3. It has increased from 5.37 (Mar 23) to 9.13, marking an increase of 3.76.
• For Quick Ratio (X), as of Mar 24, the value is 7.71. This value exceeds the healthy maximum of 2. It has increased from 3.68 (Mar 23) to 7.71, marking an increase of 4.03.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 3.07. This value is below the healthy minimum of 4. It has decreased from 7.20 (Mar 23) to 3.07, marking a decrease of 4.13.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 6.69. This value is below the healthy minimum of 20. It has increased from 4.46 (Mar 23) to 6.69, marking an increase of 2.23.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 5.89. This value is below the healthy minimum of 20. It has increased from 4.14 (Mar 23) to 5.89, marking an increase of 1.75.
• For Earning Retention Ratio (%), as of Mar 24, the value is 93.31. This value exceeds the healthy maximum of 70. It has decreased from 95.54 (Mar 23) to 93.31, marking a decrease of 2.23.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 94.11. This value exceeds the healthy maximum of 70. It has decreased from 95.86 (Mar 23) to 94.11, marking a decrease of 1.75.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 249.04. This value is within the healthy range. It has increased from 195.73 (Mar 23) to 249.04, marking an increase of 53.31.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 171.61. This value is within the healthy range. It has increased from 136.52 (Mar 23) to 171.61, marking an increase of 35.09.
• For Enterprise Value (Cr.), as of Mar 24, the value is 11,309.92. It has decreased from 12,708.88 (Mar 23) to 11,309.92, marking a decrease of 1,398.96.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 5.33. This value exceeds the healthy maximum of 3. It has increased from 4.20 (Mar 23) to 5.33, marking an increase of 1.13.
• For EV / EBITDA (X), as of Mar 24, the value is 18.67. This value exceeds the healthy maximum of 15. It has increased from 14.20 (Mar 23) to 18.67, marking an increase of 4.47.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 5.82. This value exceeds the healthy maximum of 3. It has increased from 4.37 (Mar 23) to 5.82, marking an increase of 1.45.
• For Retention Ratios (%), as of Mar 24, the value is 93.30. This value exceeds the healthy maximum of 70. It has decreased from 95.53 (Mar 23) to 93.30, marking a decrease of 2.23.
• For Price / BV (X), as of Mar 24, the value is 6.43. This value exceeds the healthy maximum of 3. It has decreased from 8.57 (Mar 23) to 6.43, marking a decrease of 2.14.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 5.82. This value exceeds the healthy maximum of 3. It has increased from 4.37 (Mar 23) to 5.82, marking an increase of 1.45.
• For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 23) to 0.03, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness